Targeting the FBXW7-AKAP13-YAP axis suppresses gliomagenesis by dual inhibition of tumor invasion and macrophage recruitment
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2026.117677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Changfu Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: A Kinase Anchor Proteins, Glioma, F-Box-WD Repeat-Containing Protein 7, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Health Commission of Henan Province, Department of Science and Technology of Henan Province, Henan Province Science and Technology Innovation Talent Program.
Abstract (Originalsprache)
Glioma, a highly lethal and common malignant tumor of the central nervous system, is characterized by its aggressive invasive behavior. Tumor-associated macrophage (TAM) represent the most abundant infiltrating immune cell population in the glioma microenvironment and play a critical role in gliomagenesis and progression. Although A-kinase anchoring protein 13 (AKAP13) has been implicated in other cancers, its specific role in glioma progression and TAM infiltration remains unclear. In this study, we identify AKAP13 is significantly upregulated in glioma tissues and associated with poor patient survival. Functionally, AKAP13 silencing inhibited glioma cell invasion and TAM recruitment in both in vitro and in vivo models. Mechanistically, AKAP13 drives tumor progression by enhancing YAP expression and nuclear translocation, which subsequently upregulates the TAM-recruiting chemokines CSF1 and CCL2. We further identified F-box and WD repeat domain-containing 7 (FBXW7) as an upstream regulator that promotes ubiquitin-mediated degradation of AKAP13. Together, our findings reveal a novel FBXW7/AKAP13/YAP/chemokine signaling axis that promotes glioma pathogenesis through both tumor-autonomous invasion and TAM recruitment, highlighting a promising therapeutic target for this lethal malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
- Department of Neurosurgery, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Electronic address: hnsyqrj@zzu.edu.cn.
Förderung
- Health Commission of Henan Province
- Department of Science and Technology of Henan Province
- Henan Province Science and Technology Innovation Talent Program
Zitieren
APA
Zhang, C., Li, H., Gao, Y., Deng, K., & Qian, R. (2026). Targeting the FBXW7-AKAP13-YAP axis suppresses gliomagenesis by dual inhibition of tumor invasion and macrophage recruitment. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.117677
Vancouver
Zhang C, Li H, Gao Y, Deng K, Qian R. Targeting the FBXW7-AKAP13-YAP axis suppresses gliomagenesis by dual inhibition of tumor invasion and macrophage recruitment. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.117677
BibTeX
@article{Zhang2026,
author = {Zhang, Changfu and Li, Haichun and Gao, Yushuai and Deng, Kaiyuan and Qian, Rongjun},
title = {Targeting the FBXW7-AKAP13-YAP axis suppresses gliomagenesis by dual inhibition of tumor invasion and macrophage recruitment},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2026.117677}
}
EUVIMED